Epicore Biosystems, Inc. was awarded a $599,872 Project Grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to develop wearable microfluidic systems for measuring sweat biomarkers in cystic fibrosis patients during exercise in remote settings. The grant was awarded under the Cardiovascular Diseases Research program, which aims to foster cardiovascular research and training through competitive grants.
Under this award, Epicore Biosystems will create a wearable microfluidic patch system and smartphone application to continuously monitor electrolyte levels and sweat rates in cystic fibrosis patients during exercise. The system aims to provide actionable hydration and electrolyte replenishment guidance to support intensive exercise. This quantitative, remote monitoring approach could enable new care management models for cystic fibrosis patients. The work is expected to be completed by August 2023 and may provide foundational insights into optimizing cystic fibrosis health outcomes through exercise.
Generated 1/7/24, 3:45 AM